Department Interventional Radiology Unit, Imaging Department, Gustave Roussy Cancer Campus, 114 rue Edouard Vaillant, 94805, Villejuif, France.
Université Paris-Sud, Le Kremlin Bicêtre, France.
Cardiovasc Intervent Radiol. 2020 Jul;43(7):1041-1048. doi: 10.1007/s00270-020-02480-y. Epub 2020 May 7.
To assess safety and efficacy of multi-level vertebroplasty, when treating 6 or more levels in the same procedural setting for the management of osteoporotic vertebral compression fractures (oVCF) in cancer patients.
Single institution retrospective review from 2015 to 2019 of patients treated for multi-level oVCF in a single session procedural setting by vertebroplasty of 6 or more levels. Procedure outcomes collected included procedural complications, pre- and 4 week post-procedure pain score by numeric rating scale, opioid usage, and vertebral height changes.
In total, 197 vertebral levels were treated in 24 procedures (mean 8.2 ± 1.8 levels). Mean procedure duration was 167 + / - 41 min, and mean postoperative hospitalization duration was 2.1 + / - 1.9 days. Four grade I or II complications occurred according to CIRSE classification. Two patients had a symptomatic pulmonary cement embolism; although there was no statistical difference between pre- and postoperative mean blood saturation (95.9 + / - 1.7% and 94.8 + / - 2.0%, respectively, p = 0.066). Pain score significantly improved after treatment (6.5 ± 1.3 vs 3.2 + / - 1.4, p < 0.0001) with a mean decrease of 3.3 (51%). Post-procedure daily opioid use also significantly improved (mean 35.8 + / - 36.8 mg/24 h vs 18.5 + / - 27.8 mg/24 h, p = 0.0089), with a mean decrease of 17.3 mg/24 h (48%). Refracture was found in 2 of 105 levels treated (1.9%), and no difference was found in thoraco-lumbar height and angulation. Five patients experienced new painful fractures at a non-treated level.
Multi-level vertebroplasty for 6 or more levels is a safe and effective treatment for the management of multi-level oVCF in cancer patients.
评估多节段椎体成形术在同一治疗程序中治疗 6 个或更多椎体时治疗癌症患者骨质疏松性椎体压缩性骨折(oVCF)的安全性和疗效。
对 2015 年至 2019 年在同一治疗程序中单次治疗 6 个或更多 oVCF 的患者进行回顾性单机构研究。收集的治疗结果包括治疗并发症、术前和术后 4 周的数字评分量表疼痛评分、阿片类药物使用和椎体高度变化。
共治疗 24 例患者的 197 个椎体(平均 8.2±1.8 个椎体)。平均手术时间为 167±41 分钟,平均术后住院时间为 2.1±1.9 天。根据 CIRSE 分类,有 4 例 I 级或 II 级并发症。2 例患者出现症状性肺水泥栓塞;尽管术前和术后平均血氧饱和度无统计学差异(分别为 95.9±1.7%和 94.8±2.0%,p=0.066)。治疗后疼痛评分显著改善(6.5±1.3 与 3.2±1.4,p<0.0001),平均下降 3.3(51%)。术后每日阿片类药物使用也显著改善(平均 35.8±36.8mg/24h 与 18.5±27.8mg/24h,p=0.0089),平均下降 17.3mg/24h(48%)。在治疗的 105 个椎体中有 2 个(1.9%)发生再骨折,胸腰椎高度和角度无差异。5 例患者在未治疗水平发生新的疼痛性骨折。
多节段椎体成形术治疗 6 个或更多椎体是治疗癌症患者多节段 oVCF 的一种安全有效的方法。